Cite

HARVARD Citation

    Duncan, V. et al. (2017). Loss of RUNX3 expression is an independent adverse prognostic factor in diffuse large B-cell lymphoma. Leukemia & lymphoma. 58 (1), pp. 179-184. [Online]. 
  
Back to record